On this page
Henry Elkus
Insider
First SEC filing: Feb. 10, 2023 · Latest: Feb. 10, 2023
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net: $0
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Dec. 16, 2022 | NRGV | A | 43,271 | · | · | 66,684 Direct | +184.82% | Acquired | (price as of 2026-10-02) |
| Aug. 12, 2022 | NRGV | J | 55,952 | · | · | 55,952 Indirect | -50.00% | Disposed | (price as of 2026-10-02) |
| Aug. 11, 2022 | NRGV | J | 116,727 | · | · | 116,728 Indirect | -50.00% | Disposed | (price as of 2026-10-02) |
| Aug. 11, 2022 | NRGV | J | 933,838 | · | · | 933,839 Indirect | -50.00% | Disposed | (price as of 2026-10-02) |
| Aug. 11, 2022 | NRGV | J | 23,413 | · | · | 23,413 Direct | · | Acquired | (price as of 2026-10-02) |
| Aug. 11, 2022 | NRGV | J | 2,357,943 | · | · | 2,357,944 Indirect | -50.00% | Disposed | (price as of 2026-10-02) |
| July 18, 2022 | NRGV | J | 1,190,327 | · | · | 0 Indirect | -100.00% | Disposed | (price as of 2026-10-02) |
| Feb. 11, 2022 | NRGV | A | 1,190,327 | · | · | 1,190,327 Indirect | · | Acquired | (price as of 2026-10-02) |
| Feb. 11, 2022 | NRGV | A | 233,455 | · | · | 233,455 Indirect | · | Acquired | (price as of 2026-10-02) |
| Feb. 11, 2022 | NRGV | A | 1,867,677 | · | · | 1,867,677 Indirect | · | Acquired | (price as of 2026-10-02) |
| Feb. 11, 2022 | NRGV | A | 4,715,887 | · | · | 4,715,887 Indirect | · | Acquired | (price as of 2026-10-02) |
| Feb. 11, 2022 | NRGV | A | 1,608,009 | · | · | 1,608,009 Indirect | · | Acquired | (price as of 2026-10-02) |
| Feb. 11, 2022 | NRGV | A | 111,904 | · | · | 111,904 Indirect | · | Acquired | (price as of 2026-10-02) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.